 | • レポートコード：D0GIR-10965 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、生物学的製剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。生物学的製剤の種類別市場規模（治療用タンパク質、モノクローナル抗体、ワクチン）、用途別市場規模（病院、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bristol-Myers Squibb、Merck、Pfizer、Eli Lilly、Johnson & Johnson、Takeda、Baxter、F. Hoffmann-La Roche、Amgen、Abbott Laboratories、Novartis、Biogen、GlaxoSmithKline ・地域別グローバル市場分析 2015年-2020年 ・生物学的製剤の北米市場（アメリカ、カナダ、メキシコ） ・生物学的製剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・生物学的製剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・生物学的製剤の南米市場（ブラジル、アルゼンチン） ・生物学的製剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：治療用タンパク質、モノクローナル抗体、ワクチン ・用途別分析：病院、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Biological Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.9% in the forecast period of 2020 to 2025 and will expected to reach USD 373850 million by 2025, from USD 275960 million in 2019.
The Biological Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biological Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biological Drugs market has been segmented into
Therapeutic Protein
Monoclonal Antibody
Vaccine
By Application, Biological Drugs has been segmented into:
Hospitals
Ambulatory Surgical Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biological Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Biological Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biological Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Biological Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biological Drugs Market Share Analysis
Biological Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biological Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biological Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Biological Drugs are:
Bristol-Myers Squibb
Merck
Pfizer
Eli Lilly
Johnson & Johnson
Takeda
Baxter
F. Hoffmann-La Roche
Amgen
Abbott Laboratories
Novartis
Biogen
GlaxoSmithKline
Among other players domestic and global, Biological Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biological Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biological Drugs, with price, sales, revenue and global market share of Biological Drugs in 2018 and 2019.
Chapter 3, the Biological Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biological Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biological Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biological Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Biological Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biological Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Therapeutic Protein
1.2.3 Monoclonal Antibody
1.2.4 Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Biological Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Overview of Global Biological Drugs Market
1.4.1 Global Biological Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bristol-Myers Squibb SWOT Analysis
2.1.4 Bristol-Myers Squibb Product and Services
2.1.5 Bristol-Myers Squibb Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly SWOT Analysis
2.4.4 Eli Lilly Product and Services
2.4.5 Eli Lilly Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Takeda
2.6.1 Takeda Details
2.6.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Takeda SWOT Analysis
2.6.4 Takeda Product and Services
2.6.5 Takeda Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Baxter
2.7.1 Baxter Details
2.7.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Baxter SWOT Analysis
2.7.4 Baxter Product and Services
2.7.5 Baxter Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 F. Hoffmann-La Roche
2.8.1 F. Hoffmann-La Roche Details
2.8.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 F. Hoffmann-La Roche SWOT Analysis
2.8.4 F. Hoffmann-La Roche Product and Services
2.8.5 F. Hoffmann-La Roche Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Amgen SWOT Analysis
2.9.4 Amgen Product and Services
2.9.5 Amgen Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Abbott Laboratories
2.10.1 Abbott Laboratories Details
2.10.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Abbott Laboratories SWOT Analysis
2.10.4 Abbott Laboratories Product and Services
2.10.5 Abbott Laboratories Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Novartis SWOT Analysis
2.11.4 Novartis Product and Services
2.11.5 Novartis Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Biogen SWOT Analysis
2.12.4 Biogen Product and Services
2.12.5 Biogen Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 GlaxoSmithKline
2.13.1 GlaxoSmithKline Details
2.13.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GlaxoSmithKline SWOT Analysis
2.13.4 GlaxoSmithKline Product and Services
2.13.5 GlaxoSmithKline Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biological Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biological Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biological Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Biological Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biological Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Biological Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biological Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Biological Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Biological Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biological Drugs Sales and Growth Rate (2015-2020)
4.5 South America Biological Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biological Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biological Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Biological Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Biological Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Biological Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Biological Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Biological Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biological Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Biological Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biological Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Biological Drugs Sales and Growth Rate (2015-2020)
6.3 UK Biological Drugs Sales and Growth Rate (2015-2020)
6.4 France Biological Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Biological Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Biological Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biological Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biological Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biological Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Biological Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Biological Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Biological Drugs Sales and Growth Rate (2015-2020)
7.5 India Biological Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biological Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Biological Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biological Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Biological Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Biological Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biological Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Biological Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biological Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biological Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biological Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biological Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Biological Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Biological Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Biological Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biological Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Biological Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Biological Drugs Price by Type (2015-2020)
11 Global Biological Drugs Market Segment by Application
11.1 Global Biological Drugs Sales Market Share by Application (2015-2020)
11.2 Global Biological Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Biological Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biological Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Biological Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Biological Drugs Market Forecast (2021-2025)
12.2.2 Europe Biological Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biological Drugs Market Forecast (2021-2025)
12.2.4 South America Biological Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biological Drugs Market Forecast (2021-2025)
12.3 Biological Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Biological Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Biological Drugs Market Share Forecast by Type (2021-2025)
12.4 Biological Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Biological Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Biological Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Biological Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biological Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biological Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Biological Drugs Major Business
Table 9. Bristol-Myers Squibb Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Bristol-Myers Squibb SWOT Analysis
Table 11. Bristol-Myers Squibb Biological Drugs Product and Services
Table 12. Bristol-Myers Squibb Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Biological Drugs Major Business
Table 15. Merck Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 16. Merck SWOT Analysis
Table 17. Merck Biological Drugs Product and Services
Table 18. Merck Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Biological Drugs Major Business
Table 21. Pfizer Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer Biological Drugs Product and Services
Table 24. Pfizer Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 26. Eli Lilly Biological Drugs Major Business
Table 27. Eli Lilly Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 28. Eli Lilly SWOT Analysis
Table 29. Eli Lilly Biological Drugs Product and Services
Table 30. Eli Lilly Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Biological Drugs Major Business
Table 33. Johnson & Johnson Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 34. Johnson & Johnson SWOT Analysis
Table 35. Johnson & Johnson Biological Drugs Product and Services
Table 36. Johnson & Johnson Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Takeda Basic Information, Manufacturing Base and Competitors
Table 38. Takeda Biological Drugs Major Business
Table 39. Takeda Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 40. Takeda SWOT Analysis
Table 41. Takeda Biological Drugs Product and Services
Table 42. Takeda Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Baxter Basic Information, Manufacturing Base and Competitors
Table 44. Baxter Biological Drugs Major Business
Table 45. Baxter Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 46. Baxter SWOT Analysis
Table 47. Baxter Biological Drugs Product and Services
Table 48. Baxter Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 50. F. Hoffmann-La Roche Biological Drugs Major Business
Table 51. F. Hoffmann-La Roche Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 52. F. Hoffmann-La Roche SWOT Analysis
Table 53. F. Hoffmann-La Roche Biological Drugs Product and Services
Table 54. F. Hoffmann-La Roche Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Amgen Basic Information, Manufacturing Base and Competitors
Table 56. Amgen Biological Drugs Major Business
Table 57. Amgen Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 58. Amgen SWOT Analysis
Table 59. Amgen Biological Drugs Product and Services
Table 60. Amgen Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Abbott Laboratories Biological Drugs Major Business
Table 63. Abbott Laboratories Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 64. Abbott Laboratories SWOT Analysis
Table 65. Abbott Laboratories Biological Drugs Product and Services
Table 66. Abbott Laboratories Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Biological Drugs Major Business
Table 69. Novartis Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 70. Novartis SWOT Analysis
Table 71. Novartis Biological Drugs Product and Services
Table 72. Novartis Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Biogen Basic Information, Manufacturing Base and Competitors
Table 74. Biogen Biological Drugs Major Business
Table 75. Biogen Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 76. Biogen SWOT Analysis
Table 77. Biogen Biological Drugs Product and Services
Table 78. Biogen Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 80. GlaxoSmithKline Biological Drugs Major Business
Table 81. GlaxoSmithKline Biological Drugs Total Revenue (USD Million) (2018-2019)
Table 82. GlaxoSmithKline SWOT Analysis
Table 83. GlaxoSmithKline Biological Drugs Product and Services
Table 84. GlaxoSmithKline Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Biological Drugs Sales by Manufacturer (2018-2019) (K MT)
Table 86. Global Biological Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Biological Drugs Sales by Regions (2015-2020) (K MT)
Table 88. Global Biological Drugs Sales Market Share by Regions (2015-2020)
Table 89. Global Biological Drugs Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Biological Drugs Sales by Countries (2015-2020) (K MT)
Table 91. North America Biological Drugs Sales Market Share by Countries (2015-2020)
Table 92. North America Biological Drugs Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Biological Drugs Revenue Market Share by Countries (2015-2020)
Table 94. Europe Biological Drugs Sales by Countries (2015-2020) (K MT)
Table 95. Europe Biological Drugs Sales Market Share by Countries (2015-2020)
Table 96. Europe Biological Drugs Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Biological Drugs Sales by Regions (2015-2020) (K MT)
Table 98. Asia-Pacific Biological Drugs Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Biological Drugs Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Biological Drugs Sales by Countries (2015-2020) (K MT)
Table 101. South America Biological Drugs Sales Market Share by Countries (2015-2020)
Table 102. South America Biological Drugs Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Biological Drugs Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Biological Drugs Sales by Countries (2015-2020) (K MT)
Table 105. Middle East & Africa Biological Drugs Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Biological Drugs Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Biological Drugs Revenue Market Share by Countries (2015-2020)
Table 108. Global Biological Drugs Sales by Type (2015-2020) (K MT)
Table 109. Global Biological Drugs Sales Share by Type (2015-2020)
Table 110. Global Biological Drugs Revenue by Type (2015-2020) (USD Million)
Table 111. Global Biological Drugs Revenue Share by Type (2015-2020)
Table 112. Global Biological Drugs Sales by Application (2015-2020) (K MT)
Table 113. Global Biological Drugs Sales Share by Application (2015-2020)
Table 114. Global Biological Drugs Sales Forecast by Regions (2021-2025) (K MT)
Table 115. Global Biological Drugs Market Share Forecast by Regions (2021-2025)
Table 116. Global Biological Drugs Sales Forecast by Type (2021-2025) (K MT)
Table 117. Global Biological Drugs Market Share Forecast by Type (2021-2025)
Table 118. Global Biological Drugs Sales Forecast by Application (2021-2025)
Table 119. Global Biological Drugs Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biological Drugs Picture
Figure 2. Global Sales Market Share of Biological Drugs by Type in 2019
Figure 3. Therapeutic Protein Picture
Figure 4. Monoclonal Antibody Picture
Figure 5. Vaccine Picture
Figure 6. Biological Drugs Sales Market Share by Application in 2018
Figure 7. Hospitals Picture
Figure 8. Ambulatory Surgical Centers Picture
Figure 9. Others Picture
Figure 10. Global Biological Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Biological Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Biological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Biological Drugs Sales Market Share by Manufacturer in 2019
Figure 31. Global Biological Drugs Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Biological Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Biological Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Biological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Biological Drugs Revenue Market Share by Regions (2015-2020)
Figure 38. Global Biological Drugs Revenue Market Share by Regions in 2018
Figure 39. North America Biological Drugs Sales and Growth Rate (2015-2020)
Figure 40. Europe Biological Drugs Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Biological Drugs Sales and Growth Rate (2015-2020)
Figure 42. South America Biological Drugs Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Biological Drugs Sales and Growth Rate (2015-2020)
Figure 44. North America Biological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Biological Drugs Sales Market Share by Countries (2015-2020)
Figure 46. North America Biological Drugs Sales Market Share by Countries in 2018
Figure 47. North America Biological Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Biological Drugs Revenue Market Share by Countries in 2018
Figure 49. United States Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Biological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Biological Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Biological Drugs Revenue Market Share by Countries in 2019
Figure 55. Germany Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Biological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Biological Drugs Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Biological Drugs Revenue Market Share by Regions 2019
Figure 63. China Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Biological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Biological Drugs Sales Market Share by Countries in 2019
Figure 70. South America Biological Drugs Revenue Market Share by Countries in 2019
Figure 71. Brazil Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Biological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Biological Drugs Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Biological Drugs Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Biological Drugs Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Biological Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Biological Drugs Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Biological Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Biological Drugs Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Biological Drugs Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Biological Drugs Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Biological Drugs Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Biological Drugs Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
生物学的接着剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Biological Adhesive market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- バイオ工学によるタンパク質医薬品の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Bioengineered Protein Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 100270 million by 2025, from USD 86200 million in 2019. The Bioengine…
- 生体防御の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Biological Defense market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 治療用酵素薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Therapeutic Enzyme Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- バイオロジカルマススペクトロメトリー（BMS）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Biological Mass Spectrometry market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…